Di Lu

Title: Di Lu - Innovator in Sustained Release Pharmaceutical Composition

Introduction

Di Lu is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release compositions. His innovative work aims to enhance the efficacy and patient compliance of medication.

Latest Patents

Di Lu holds a patent for a "Pregabalin sustained release composition and method for preparing the same." This patent describes a composition that includes an active ingredient, a matrix-forming agent, a swelling agent, a gelling agent, and optionally a filler. The composition is designed to rapidly swell in volume when exposed to an aqueous medium, exceeding the diameter of the human gastric pyloric (13 mm). This feature prolongs gastric emptying time, thereby increasing the retention time of pregabalin in the stomach and enhancing its absorption in the small intestine and ascending colon. The composition achieves a sustained release for 24 hours, allowing for once-a-day administration, reducing the number of doses, and improving patient compliance.

Career Highlights

Throughout his career, Di Lu has worked with prominent organizations such as Beijing Tide Pharmaceutical Co., Ltd. and the Chinese Academy of Sciences. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.

Collaborations

Di Lu has collaborated with notable colleagues, including Zhaolu Zhu and Yun Wu. Their combined efforts have further advanced research and development in the pharmaceutical sector.

Conclusion

Di Lu's contributions to the field of sustained release pharmaceutical compositions demonstrate his commitment to improving medication efficacy and patient adherence. His innovative approaches continue to influence the pharmaceutical industry positively.